Computed tomography in diagnosing pituitary tumours in rats - the authors’ own observations

• Autorzy: Debiak P. , Wilczynska A. , Zietek J. , Wojcik A. , Winiarczyk S. , Adaszek L.
• Języki publikacji: EN

Abstrakty

EN

The aim of this study was to present cases of rats with suspected pituitary tumours and the application of computed tomography in diagnosing pituitary tumours in rats. The study included 25 animals with symptoms suggestive of pituitary tumours (ataxia, paralyses, strabismus). The animals were submitted to a detailed clinical examination and computed tomography (CT). The CT confirmed pituitary tumours in 20 out of 25 animals. Additionally, this study enabled the proof of a definite correlation between the size of the pituitary tumour and clinical symptoms observed in sick animals. This article presents the usefulness of tomography examination in diagnosing pituitary tumours in rats and it is the first paper of this kind in Poland. However, it should be borne in mind that a CT without the use of a contrast medium only allows for the identification of neoplasm in some cases. It is the contrast-computed tomography that significantly increases diagnostic chances of this method in identification and evaluation of the size, shape and contour of proliferative lesions of the brain region in rats.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2019
• Tom: 75
• Numer: 10
• Opis fizyczny: p.622-626,fig.,ref.

Twórcy

autor

Debiak P.

• Laboratory of Radiology and Ultrasonography, Department and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland

autor

Wilczynska A.

• Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland

autor

Zietek J.

• Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland

autor

Wojcik A.

• Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland

autor

Winiarczyk S.

• Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland

autor

Adaszek L.

• Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland

Bibliografia

• Barrow D. L., Tindall G. T.: Pituitary adenomas. An update on their management with an emphasis on the role of bromocriptine. J. Clin. Neuroophthalmol. 1983, 3, 229-237.
• Bombardieri E., Seregni E., Villano C., Chiti A., Bajetta E.: Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors. Q. J. Nucl. Med. Mol. Imaging. 2004, 48, 150-163.
• Capozzi A., Scambia G., Pontecorvi A., Lello S.: Hyperprolactinemia: pathophysiology and therapeutic approach. Gynecol. Endocrinol. 2015, 31, 506-510.
• Casanueva F. F., Gordon W. L., Friesen H. G.: Computerized cranial tomography in the evaluation of pituitary tumours in rats. Acta Endocrinol. (Copenh.) 1983, 103, 487-491.
• Colao A., di Sarno A., Sarnacchiaro F., Ferone D., di Renzo G., Merola B., Annunziato L., Lombardi G.: Prolactinomas resistant to standard doamine agonists respond to chronic cabergoline treatment. J. Clin. Endcrinol. Metabol. 1997, 82, 876-883.
• Dworakowska D., Grossman A. B.: The pathophysiology of pituitary adenomas. Best. Pract. Res. Clin. Endocrinol. Metab. 2009, 23, 525-541.
• Eguchi K., Kawamoto K., Uozumi T., Ito A., Arita K., Kurisu K.: Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies. Endocr. J. 1995, 42, 413-420.
• Farrell W. E., Simpson D. J., Frost S. J., Clayton R. N.: Methylation mechanisms in pituitary tumori-genesis. Endocr. Relat. Cancer. 1999, 6, 437-447.
• Ferrari C. I., Abs R., Bevan J. S., Brabant G., Ciccarelli E., Motta T., Mucci M., Muratori M., Musatti L., Verbessem G., Scanlon M. F.: Treatment of macroprolactinoma with cabergoline: a study of 85 patients. Clin. Endocrinol. 1997, 46, 409-413.
• Godlewska A., Bielecki W., Barszcz K.: Spontaneous pituitary tumours in pet rats. Życie Wet. 2012, 87, 851-854.
• Gruszka A., Pawlikowski M., Kunert-Radek J.: Antitumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliterative and pro-apoptotic effects. Neuroendocrinol. Lett. 2001, 22, 343-348.
• Heaney A. P.: Clinical review: pituitary carcinoma – difficult diagnosis and treatment. J. Clin. Endocrinol. Metab. 2011, 96, 3649-3660.
• Hyun S. H., Choi J. Y., Lee K. H., Choe Y. S., Kim B. T.: Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria. J. Nucl. Med. 2011, 52, 547-550.
• Jane J. A., Laws E. R. Jr.: The management of non-functioning pituitary adenomas. Neurol. India 2003, 51, 461-465.
• Karasek M., Pawlikowski M., Lewiński A.: Hyperprolactinemia: causes, diagnosis, and treatment. Endokrynol. Pol. 2006, 57, 656-662.
• Lucignani G., Losa M., Moresco R. M., Del Sole A., Matarrese M., Bettinardi V., Mortini P., Giovanelli M., Fazio F.: Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethyl-spiperone. Eur. J. Nucl. Med. 1997, 24, 1149-1155.
• Ramakrishnan V. R., Suh J. D., Lee J. Y., O’Malley B. W, Jr., Grady M. S., Palmer J. N.: Sphenoid sinus anatomy and suprasellar extension of pituitary tumors. J. Neurosurg. 2013, 119, 669-674.
• Trouillas J., Girod C., Claustrat B., Cure M., Dubois M. P.: Spontaneous pituitary tumors in the Wistar/Furth/Ico rat strain An animal model of human prolactin adenoma. Am. J. Path. 1982, 109, 57-70.
• Wilczyńska A., Ziętek J., Panasiuk-Flak K., Dębiak P., Adaszek Ł.: Zastosowanie bromokryptyny w leczeniu paliatywnym guza przysadki u szczurów. Nauki przyrodnicze i medyczne: Postępy w farmakologii i onkologii 2018, p. 54-65.

Identyfikatory

DOI

10.21521/mw.6297